Community-acquired methicillin-resistant Staphylococcus aureus mycotic aneurysm.

Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) continues to emerge as a cause of serious infections. We present the first case of abdominal mycotic aneurysm caused by Panton-Valentine leukocidin-positive CA-MRSA. This case adds another presentation to the clinical spectrum of CA-MRSA infections, and highlights the problem encountered in the choice of the therapy of serious community-acquired infections in an era of increasing CA-MRSA infections.

[1]  P. Wayne.  CLINICAL AND LABORATORY STANDARDS INSTITUTE. PERFORMANCE STANDARDS FOR ANTIMICROBIAL SUSCEPTIBILITY TESTING , 2011 .

[2]  H. Boucher,et al.  Epidemiology of methicillin-resistant Staphylococcus aureus. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  R. Wenzel,et al.  Antibiotic options for treating community-acquired MRSA , 2008, Expert review of anti-infective therapy.

[4]  J. Schefold,et al.  Therapy-refractory Panton Valentine Leukocidin-positive community-acquired methicillin-sensitive Staphylococcus aureus sepsis with progressive metastatic soft tissue infection: a case report , 2007, Journal of medical case reports.

[5]  S. Micek.  Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  R. Daum.  Skin and Soft-Tissue Infections Caused by Methicillin-Resistant Staphylococcus aureus , 2007 .

[7]  F. Vandenesch,et al.  Effect of Antibiotics on Staphylococcus aureus Producing Panton-Valentine Leukocidin , 2007, Antimicrobial Agents and Chemotherapy.

[8]  R. Daum,et al.  Clinical practice. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. , 2007, The New England journal of medicine.

[9]  T. Bower.  Surgical treatment of infected aneurysms and pseudoaneurysms of the thoracic and abdominal aorta. , 2006, Perspectives in vascular surgery and endovascular therapy.

[10]  M. Pai,et al.  Epidemiology of Vancomycin-Induced Neutropenia In Patients Receiving Home Intravenous Infusion Therapy , 2006, The Annals of pharmacotherapy.

[11]  H. Maltezou,et al.  Community-acquired methicillin-resistant Staphylococcus aureus infections. , 2006, International journal of antimicrobial agents.

[12]  James S. Lewis,et al.  Treatment approaches for community-acquired methicillin-resistant Staphylococcus aureus infections , 2005, Current opinion in infectious diseases.

[13]  Yhu-Chering Huang,et al.  Community-acquired methicillin-resistant Staphylococcus aureus in Taiwan. , 2005, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[14]  D. Osmon,et al.  Epidemiology, treatment, and prevention of community-acquired methicillin-resistant Staphylococcus aureus infections. , 2005, Mayo Clinic proceedings.

[15]  William R Bishai,et al.  Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. , 2005, The Lancet. Infectious diseases.

[16]  V. Yu,et al.  Similar hematologic effects of long-term linezolid and vancomycin therapy in a prospective observational study of patients with orthopedic infections. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  R. J. Valentine,et al.  Surgical mortality in patients with infected aortic aneurysms. , 2003, Journal of the American College of Surgeons.

[18]  L. John,et al.  Linezolid versus Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections , 2002 .

[19]  C. Clase,et al.  Ruptured mycotic thoracoabdominal aortic aneurysms: a report of three cases and a systematic review. , 2001, Journal of vascular surgery.

[20]  H. Chambers,et al.  The changing epidemiology of Staphylococcus aureus? , 2001, Emerging infectious diseases.

[21]  M. Ferraro.  Performance standards for antimicrobial susceptibility testing , 2001 .